Applied Therapeutics Inc logo

Applied Therapeutics Inc

NAS:APLT (USA)  
$ 1.47 +0.01 (+0.68%) 04:00 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 85.04M
Enterprise V:
$ 62.85M
Volume:
293.27K
Avg Vol (2M):
541.92K
Also Trade In:
Volume:
293.27K
Market Cap $:
85.04M
PE Ratio:
At Loss
Avg Vol (2M):
541.92K
Enterprise Value $:
62.85M
PB Ratio:
0

Business Description

Description
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
Name Current Vs Industry Vs History
Cash-To-Debt 17.52
Equity-to-Asset -0.14
Debt-to-Equity -0.32
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -22.72
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 70.41
9-Day RSI 57.19
14-Day RSI 55.42
6-1 Month Momentum % 75.46
12-1 Month Momentum % 28.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.87
Quick Ratio 0.87
Cash Ratio 0.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.4
Name Current Vs Industry Vs History
Operating Margin % -663.29
Net Margin % -652.2
ROE % -449.19
ROA % -129.62
ROIC % -359.82
ROC (Joel Greenblatt) % -6059.91
ROCE % -436.16

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 7.78
EV-to-EBIT -0.89
EV-to-Forward-EBIT -0.85
EV-to-EBITDA -0.89
EV-to-Forward-EBITDA -0.85
EV-to-Revenue 5.9
EV-to-FCF -1.04
Earnings Yield (Greenblatt) % -112.36

Financials (Next Earnings Date:2023-08-11 Est.)

APLT's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APLT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Applied Therapeutics Inc Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.66
EPS (TTM) ($) -1.7
Beta 2.22
Volatility % 151.94
14-Day RSI 55.42
14-Day ATR ($) 0.146831
20-Day SMA ($) 1.4705
12-1 Month Momentum % 28.46
52-Week Range ($) 0.4995 - 2.18
Shares Outstanding (Mil) 57.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Applied Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Applied Therapeutics Inc Stock Events

Event Date Price($)
No Event Data

Applied Therapeutics Inc Frequently Asked Questions

What is Applied Therapeutics Inc(APLT)'s stock price today?
The current price of APLT is $1.47. The 52 week high of APLT is $2.18 and 52 week low is $0.50.
When is next earnings date of Applied Therapeutics Inc(APLT)?
The next earnings date of Applied Therapeutics Inc(APLT) is 2023-08-11 Est..
Does Applied Therapeutics Inc(APLT) pay dividends? If so, how much?
Applied Therapeutics Inc(APLT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1